Bulgari Makes Major Contribution in Fight Against COVID-19
Bulgari has just made a substantial contribution to the Lazzaro Spallanzani Hospital, which is Italy’s Institute for Infectious Diseases based in Rome. Here, three researchers, Maria Rosaria Capobianchi, Francesca Colavita and Concetta Castilletti have managed to succfully isolate the virus in under 48 hours.

(L-R) Marta Branca, General Manager of Spallanzani, researches Concetta Castilleti, Francesca Colavita and Maria Rosaria Capobianchi with Bulgari CEO, Jean-Christophe Babin
The Lazzaro Spallanzani Hospital took delivery of the microscope just ahead of the weekend with Bulgari CEO, Mr Jean-Christophe Babin present for the occasion.
Marta Branca, General Manager of Spallanzani spoke at commend Bulgari for their contribution saying, “We are honored by the donation of Bulgari which will allow us to strengthen research on the developments of COVID-19 in such a delicate moment. I thank, in particular the CEO, Jean-Christophe Babin, for his commitment and his availability towards the Institute.”

Marta Branca, General Manager of Spallanzani with Bulgari CEO, Jean-Christophe Babin

Mr Babin speaking with the team of researches working to develop a vaccine against COVID-19 at the Lazzaro Spallanzani Hospital


